Skip to main content
. 2012 Oct 4;2012:456534. doi: 10.1155/2012/456534

Figure 2.

Figure 2

Kaplan-Meier overall (a) and progression-free (b) survival curves for epithelial ovarian cancer patients with high and low RUNX2 expression. Epithelial ovarian cancer patients with high RUNX2 expression had significantly shorter overall (P < 0.001) and progression-free (P = 0.002) survival than those with low RUNX2 expression did.